AP Anthony Bosch

Who is Anthony Bosch?

40 Comments

In the wake of ESPN’s Tuesday night report about Major League Baseball’s investigation and potential suspension of as many as two dozen players linked to the Biogenesis clinic in Miami, the spotlight has shone on one man more than any other: Anthony Bosch, the owner of the Biogenesis of America clinic and now the man who is reportedly prepared to turn over everything he knows about his famous clients to Major League Baseball.

But who is Anthony Bosch? What do we know about him?

Not much. We know he was born in Miami and grew up in comfortable circumstances. His father, Pedro Bosch, has been a successful physician for nearly 40 years. He has had multiple marriages and multiple failed businesses, with Biogenesis being the last.

Biogenesis was an “anti-aging” clinic that, superficially anyway, was like many in Florida. It was just across U.S. 1 from the University of Miami, housed in what was once a motel. Like other anti-aging clinics, it was a quasi-medical establishment which offered its mostly wealthy clients assistance in weight loss, physical fitness, and in some cases psychological services. Better living through therapy and chemistry. Such clinics are not licensed or regulated by the State of Florida.

The “quasi” part of that comes from the fact that Bosch is not a physician. His only known degree was obtained in 2009 from the Central America Health Sciences University in Belize, which he claimed to be a medical degree and displayed it on his office wall. According to the Miami New Times he wore a lab coat with “Dr. Tony Bosch” on it and gave the impression to many that he was, in fact, a doctor.

He did something else only doctors are allowed to do: as the New York Times reported in February, Bosch would obtain prescription drugs for his patients, including human growth hormone. His methods of doing so is unknown and are subject to an investigation by the Florida Department of Health and referrals to the Miami State Attorney’s office and the Florida Attorney General’s office. The New York Times report on Biogenesis in February described Bosch’s clinic as disheveled and disorganized. A former business partner of Bosch’s was surprised that Bosch was alleged to have worked with high-profile athletes, saying “I don’t know how the guy can tie his shoes, let alone have A-Rod as a client.”

But his business records, obtained by the Miami New Times suggest that he did indeed supply performance enhancing drugs to many ballplayers, A-Rod included. Most of the drug distributions were reported to have been made through intermediaries rather than to the ballplayers themselves. One of the alleged intermediaries was an employee of player agents the Levinson brothers. In the case of Alex Rodriguez, however, Bosch is alleged to have actually injected the player personally, doing so at Rodriguez’s home. All involved have denied the allegations.

Bosch himself denied any allegation that he supplied performance enhancing drugs to players, telling ESPN in April that such allegations are lies:

“I have been accused, tried and convicted in the media. And so I think have been falsely accused throughout the media … I am a nutritionist. I don’t know anything about performance-enhancing drugs.”

But that has all changed now. Major League Baseball sued Bosch in March, alleging that he tortiously interfered with baseball’s Joint Drug Agreement, damaging the game. On Thursday morning it was reported that, some time after that suit was filed, Bosch approached Alex Rodriguez in an effort to obtain his financial assistance in the face of the lawsuit and other investigations into his activities. Rodriguez is reported to have denied any assistance to Bosch.

Now, Bosch and Major League Baseball are reported to have come to an agreement in which the lawsuit will be dismissed against him, he will provide testimony and documents to Major League Baseball in furtherance of its investigation into Biogenesis-connected ballplayers and will indemnify him for any legal repercussions occasioned by his cooperation. While the baseball officials have not yet spoken to Bosch, it is reasonable to assume that the league’s cooperation with Bosch is based on him providing information which would implicate ballplayers in the use of performance enhancing drugs.

Orioles are eying Welington Castillo as their primary catcher target

BALTIMORE, MD - SEPTEMBER 25: Welington Castillo #7 of the Arizona Diamondbacks warms up prior to taking an at bat against the Baltimore Orioles in the second inning at Oriole Park at Camden Yards on September 25, 2016 in Baltimore, Maryland. (Photo by Matt Hazlett/Getty Images)
Getty Images
Leave a comment

A report from the Baltimore Sun’s Dan Connolly suggests that free agent catcher Welington Castillo currently tops the Orioles’ list of potential backstop targets for the 2017 season. With Matt Wieters on the market, the Orioles lack a suitable platoon partner for Caleb Joseph behind the dish, and Connolly adds that the club has been discussing a multi-year deal with Castillo’s representatives since the Winter Meetings.

Castillo batted .264/.322/.423 with the Diamondbacks in 2016, racking up 14 home runs and driving in a career-high 68 RBI in 457 PA. His bat provides much of his upside, and Connolly quoted an anonymous National League scout who believes that the 29-year-old’s defensive profile has fallen short of his potential in recent years.

For better or worse, both the Orioles and Castillo appear far from locking in a deal for 2017. Both the Rays and Braves have expressed interest in the veteran catcher during the past week, while the Orioles are reportedly considering Wieters, Nick Hundley and Chris Iannetta as alternatives behind the plate.

Report: Phillies agree to minor league deal with Daniel Nava

KANSAS CITY, MO - SEPTEMBER 12:  Daniel Nava #12 of the Kansas City Royals bats during the game against the Oakland Athletics at Kauffman Stadium on September 12, 2016 in Kansas City, Missouri.  (Photo by Jamie Squire/Getty Images)
Getty Images
2 Comments

The Phillies reportedly signed veteran outfielder Daniel Nava to a minor league contract, according to Matt Gelb of the Philadelphia Inquirer.

Nava began the season on a one-year contract with the Angels, during which he slashed .235/.309/.303 through 136 PA in the first half of 2016. He was flipped to the Royals in late August for a player to be named later and saw the remainder of his year go down the drain on an .091 average through 12 PA in Anaheim. After getting the boot from the Angels’ 40-man roster in November, the 33-year-old outfielder elected free agency.

Nava is expected to compete for a bench role on the Phillies’ roster in the spring. As it currently stands, the club’s projected 2017 outfield features Howie Kendrick and Odubel Herrera, with precious little depth behind them. Nava’s bat is underwhelming, but at the very least he offers the Phillies a warm body in left field and a potential platoon partner for one of their younger options, a la Tyler Goeddel or Roman Quinn.